Latest Articles
-
Can Pfizer Stock Outrun A $17B Revenue Void?
The true narrative for Pfizer (PFE) is not its recent top line earnings beat but the escalating structural tension between its required research spending and an impending revenue void. First quarter 2026 results showed an adjusted earnings per sh...
-
Years of Rewards: $57 Bil From Pfizer Stock
In the last five years, Pfizer (PFE) stock has returned a notable $57 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market...
-
Pfizer Stock To $20?
Our multi-factor assessment suggests that it may be time to sell PFE stock. We have, overall, a pessimistic view of the stock, and a price of $20 may not be out of reach. We believe there are several things to fear in PFE stock given its overall...
-
Could This Fuel The Next Surge in Pfizer Stock
Pfizer has demonstrated remarkable rallies, with its stock surging over 30% in under two months during key periods like 8232021 and 12152021. These swift upswings have rewarded investors with substantial gains. If similar catalysts emerge, Pfizer...
-
Pfizer Stock To $20?
Our multi-factor assessment suggests that it may be time to sell PFE stock. We have, overall, a pessimistic view of the stock, and a price of $20 may not be out of reach. We believe there are a few things to fear in PFE stock given its overall W...
-
Is Pfizer Stock Heading for a Fall?
Pfizer (PFE) is facing threats. Even the biggest names aren’t invincible. Stocks can drop sharply without warning – wiping out months or years of gains in a matter of weeks. History shows that sudden market swings can hit any company,...
-
Ten-Year Tally: Pfizer Stock Delivers $68 Bil Gain
In the last decade, Pfizer (PFE) stock has returned a notable $68 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the marketR...
-
What Could Send Pfizer Stock Soaring
Pfizer has demonstrated remarkable rallies, with its stock surging over 30% in under two months during key periods like 8232021 and 12152021. These swift upswings have rewarded investors with substantial gains. If similar catalysts emerge, Pfizer...
-
Buy or Sell Pfizer Stock?
We believe there are a few things to fear in PFE stock given its overall Weak operating performance and financial condition. This is aligned with the stock’s Low valuation because of which we think it is Fairly Priced . Below is our asses...
-
What Can Cause Pfizer Stock To Crash?
Pfizer (PFE) is facing threats. Even the biggest names aren’t invincible. Stocks can drop sharply without warning – wiping out months or years of gains in a matter of weeks. History shows that sudden market swings can hit any company,...
-
What Could Send Pfizer Stock Soaring
Pfizer has demonstrated remarkable rallies, with its stock surging over 30% in under two months during key periods like 8232021 and 12152021. These swift upswings have rewarded investors with substantial gains. If similar catalysts emerge, Pfizer...
-
A Decade of Rewards: $68 Bil From Pfizer Stock
In the last decade, Pfizer (PFE) stock has returned a notable $68 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the marketR...
-
Pfizer Stock Capital Return Hits $68 Bil
In the last decade, Pfizer (PFE) stock has returned a notable $68 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the marketR...
-
Pfizer Stock Shares $68 Bil Success With Investors
In the last decade, Pfizer (PFE) stock has returned a notable $68 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the marketR...
-
Pfizer Stock To $32?
Our multi-factor assessment suggests that it may be time to buy more shares of PFE stock. We have, overall, a positive view of the stock, and a price of $32 may not be out of reach. We believe there is a near-equal mix of good and bad in PFE sto...
